Stephen L Isaacs
age ~86
from San Francisco, CA
- Also known as:
-
- Stephen J Isaacs
- Stephen A Isaacs
- Stephen H Isaacs
- Steven L Isaacs
- Steph L Isaacs
- Stephens L Isaacs
- Anna Seirsdale
- Ana Seirsdale
- Phone and address:
-
845 25Th Ave, San Francisco, CA 94121
(415)7527985
Stephen Isaacs Phones & Addresses
- 845 25Th Ave, San Francisco, CA 94121 • (415)7527985
- 847 25Th Ave, San Francisco, CA 94121 • (415)3861535 • (415)3863263 • (415)3863265
- 1717 Michael Way, Calistoga, CA 94515
- 65 Harmon Ave, Pelham, NY 10803 • (914)6331407
- New York, NY
- Yonkers, NY
- Napa, CA
Work
-
Address:845 25Th Ave, San Francisco, CA 94121
Education
-
School / High School:Columbia
Ranks
-
Licence:New York - Delinquent
-
Date:1966
Isbn (Books And Publications)
To Improve Health and Health Care 2000: The Robert Wood Johnson Foundation Anthology
view sourceAuthor
Stephen I. Isaacs
ISBN #
0787949760
The Consumer's Legal Guide to Today's Health Care: Your Medical Rights and How to Assert Them
view sourceAuthor
Stephen L. Isaacs
ISBN #
0395574382
The Consumer's Legal Guide to Today's Health Care: Your Medical Rights and How to Assert Them
view sourceAuthor
Stephen L. Isaacs
ISBN #
0395632773
To Improve Health and Health Care: The Robert Wood Johnson Foundation Anthology
view sourceAuthor
Stephen L. Isaacs
ISBN #
0608262234
To Improve Health and Health Care: The Robert Wood Johnson Foundation Anthology
view sourceAuthor
Stephen L. Isaacs
ISBN #
0787909092
To Improve Health and Health Care, 1998-1999: The Robert Wood Johnson Foundation Anthology
view sourceAuthor
Stephen L. Isaacs
ISBN #
0787943916
Us Patents
-
Psoralen Compounds
view source -
US Patent:6420570, Jul 16, 2002
-
Filed:Jan 22, 2001
-
Appl. No.:09/767611
-
Inventors:Susan Wollowitz - Walnut Creek CA
Stephen T. Isaacs - Orinda CA
Henry Rapoport - Berkeley CA
Hans Peter Spielmann - Lexington KY -
Assignee:Cerus Corporation - Concord CA
-
International Classification:C07D49300
-
US Classification:549282
-
Abstract:Psoralen compound compositions are synthesized which have substitutions on the 4, 4â, 5â, and 8 positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these bound psoralens result in covalent crosslinking to nucleic acid, thereby inactivating the pathogen. Higher psoralen binding levels and lower mutagenicity results in safer, more efficient, and reliable inactivation of pathogens. In addition to the psoralen compositions, the invention contemplates inactivating methods using the new psoralens.
-
Device And Method For Photoactivation
view source -
US Patent:6461567, Oct 8, 2002
-
Filed:Jun 11, 2001
-
Appl. No.:09/878542
-
Inventors:David Paul Hearst - Redwood City CA
George D. Cimino - Lafayette CA
John Eugene Hearst - Berkeley CA
Stephen T. Isaacs - Orinda CA -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A61L 200
-
US Classification:422 22, 422 24, 422 44, 25045511
-
Abstract:A device comprising a light source, a sample holder and a temperature control chamber. The sample holder supports the vessels in a fixed relationship relative to the light source. The temperature control chamber surrounds the sample holder and vessels, so that a temperature control fluid may be passed around the sample vessels effectively maintaining the temperature of the sample vessels within a desired temperature range.
-
Compounds For The Photodecontamination Of Pathogens In Blood
view source -
US Patent:6469052, Oct 22, 2002
-
Filed:Jan 22, 2001
-
Appl. No.:09/767608
-
Inventors:Susan Wollowitz - Lafayette CA
Stephen T. Isaacs - Orinda CA
Henry Rapoport - Berkely CA
Hans Peter Spielmann - Lexington KY -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A61K 3135
-
US Classification:514455, 549282
-
Abstract:The present invention includes compositions comprising new psoralens with either a or primary amino substituent and a blood product that is suitable for in vivo use. The compositions are useful for the inactivation of pathogens in blood products such as platelets and plasma.
-
Method For Photodecontamination Of Pathogens In Blood Using 5-Primary Aminopsoralens
view source -
US Patent:6503699, Jan 7, 2003
-
Filed:Aug 16, 1999
-
Appl. No.:09/375340
-
Inventors:Susan Wollowitz - Walnut Creek CA
Stephen T. Isaacs - Orinda CA
Henry Rapoport - Berkeley CA
Hans Peter Spielmann - Lexington KY -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A01N 102
-
US Classification:435 2, 435238, 549282
-
Abstract:Psoralen compound compositions are synthesized which have substitutions on the 4, 4â, 5â, and 8 positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these bound psoralens result in covalent crosslinking to nucleic acid, thereby inactivating the pathogen. Higher psoralen binding levels and lower mutagenicity results in safer, more efficient, and reliable inactivation of pathogens. In addition to the psoralen compositions, the invention contemplates inactivating methods using the new psoralens.
-
Device And Method For Photoactivation
view source -
US Patent:6680025, Jan 20, 2004
-
Filed:Sep 6, 2002
-
Appl. No.:10/236373
-
Inventors:David Paul Hearst - Redwood City CA
George D. Cimino - Lafayette CA
John Eugene Hearst - Berkeley CA
Stephen T. Isaacs - Orinda CA -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A61L 200
-
US Classification:422 22, 25045511, 250504 R, 422 20, 422 24, 4221863
-
Abstract:A device containing a light source, a sample support and a temperature control compartment. The sample support is positioned to support multiple sample vessels for irradiation by the light source. The temperature control compartment maintains the temperature of the sample vessels within a desired range. The light source, sample support and temperature control compartment are all contained within an opaque housing.
-
Compounds For The Photodecontamination Of Pathogens In Blood
view source -
US Patent:6686480, Feb 3, 2004
-
Filed:Jun 3, 2002
-
Appl. No.:10/161589
-
Inventors:Susan Wollowitz - Lafayette CA
Stephen T. Isaacs - Orinda CA
Henry Rapoport - Berkeley CA
Hans Peter Spielmann - Lexington KY -
Assignee:Cerus Corporation - Concord CA
-
International Classification:C07D49300
-
US Classification:549282
-
Abstract:Psoralen compound compositions are synthesized which have substitutions on the 4, 4â, 5â, and 8 positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these bound psoralens result in covalent crosslinking to nucleic acid, thereby inactivating the pathogen. Higher psoralen binding levels and lower mutagenicity results in safer, more efficient, and reliable inactivation of pathogens. In addition to the psoralen compositions, the invention contemplates inactivating methods using the new psoralens.
-
Compounds For The Photodecontamination Of Pathogens In Blood
view source -
US Patent:20030185804, Oct 2, 2003
-
Filed:Aug 6, 2002
-
Appl. No.:10/213138
-
Inventors:Susan Wollowitz - Lafayette CA, US
Stephen Isaacs - Orinda CA, US
Henry Rapoport - Berkeley CA, US
Hans Spielmann - Lexington KY, US -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A61K045/00
A01N001/02
A61K031/366 -
US Classification:424/093700, 514/455000, 435/002000
-
Abstract:Psoralen compounds are synthesized which have substitutions on the 4, 4′, 5′, and 8 positions of the psoralen, which permit enhanced binding to nucleic acid of pathogens. Higher psoralen binding levels and lower mutagenicity are described, resulting in safer, more efficient, and reliable inactivation of pathogens in blood products. The invention contemplates inactivation methods using the new psoralens which do not compromise the function of blood products for transfusion.
-
Method For The Photo-Decontamination Of Pathogens In Blood Using 4'-Primary Amino Psoralens
view source -
US Patent:59725931, Oct 26, 1999
-
Filed:Mar 30, 1998
-
Appl. No.:9/050882
-
Inventors:Susan Wollowitz - Walnut Creek CA
Stephen T. Isaacs - Orinda CA
Henry Rapoport - Berkeley CA
Hans Peter Spielmann - Lexington KY -
Assignee:Cerus Corporation - Concord CA
-
International Classification:A01N 102
C12N 706 -
US Classification:435 2
-
Abstract:Psoralen compound compositions are synthesized which have substitutions on the 4, 4', 5', and 8 positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these bound psoralens result in covalent crosslinking to nucleic acid, thereby inactivating the pathogen. Higher psoralen binding levels and lower mutagenicity results in safer, more efficient, and reliable inactivation of pathogens. In addition to the psoralen compositions, the invention contemplates inactivating methods using the new psoralens.
Amazon
The Nursing Profession: Development, Challenges, and Opportunities
view sourceThe Nursing Profession: Development, Challenges, and Opportunities is designed to be a resource for those who are interested in or touched by nursing. This book is designed in part to complement the report by the Institute of Medicine on the future of nursing. Readers—whether researchers or practiti...
Binding
Paperback
Pages
424
Publisher
Jossey-Bass
ISBN #
1118028813
EAN Code
9781118028810
ISBN #
3
Palliative Care: Transforming the Care of Serious Illness
view sourcePalliative Care is the first book to provide a comprehensive understanding of the new field that is transforming the way Americans deal with serious illness. Diane E. Meier, M.D., one of the field's leaders and a recipient of a MacArthur Foundation "genius award" in 2009, opens the volume with a swe...
Binding
Paperback
Pages
464
Publisher
Jossey-Bass
ISBN #
047052717X
EAN Code
9780470527177
ISBN #
2
Lawyers & Attorneys
Stephen Laurence Isaacs, San Francisco CA - Lawyer
view sourceAddress:
845 25Th Ave, San Francisco, CA 94121
Licenses:
New York - Delinquent 1966
Education:
Columbia
Stephen Isaacs - Lawyer
view sourceISLN:
916554888
Admitted:
1999
University:
Southeast Missouri State University, B.S., 1996
Law School:
University of Missouri, Columbia, J.D., 1999
Stephen L. Isaacs, Pelham NY - Lawyer
view sourceOffice:
65 Harmon Ave., Pelham, NY
Specialties:
Health Care(100%)
ISLN:
900997295
Admitted:
1966
University:
Brown University, A.B.
Law School:
Columbia University, J.D.
Name / Title
Company / Classification
Phones & Addresses
President
Aduro Gvax Inc
626 Bancroft Way, Berkeley, CA 94710
President
HEALTH POLICY ASSOCIATES, INC
847 25 Ave, San Francisco, CA 94121
REDAMAX ENTERPRISES MIDWEST,LLC
President
Nanotx Corp
Commercial Physical Research, Nsk
Commercial Physical Research, Nsk
626 Bancroft Way, Berkeley, CA 94710
Director
Royce Micro-Cap Trust, Inc
Management Investment, Open-End, Nsk
Management Investment, Open-End, Nsk
1414 Ave Of The Americas, New York, NY 10019
Director
ROYCE VALUE TRUST, INC
Closed In Investment Trust
Closed In Investment Trust
1414 Ave Of The Americas, New York, NY 10019
(212)3557311
(212)3557311
President
Center for Health & Social Policy Inc
Individual/Family Services
Individual/Family Services
847 25 Ave, San Francisco, CA 94121
THE CENTER FOR HEALTH AND SOCIAL POLICY, INC
65 Harmon Ave, Pelham, NY 10803
Resumes
Chairman And Chief Executive Officer
view sourceLocation:
San Francisco, CA
Industry:
Biotechnology
Work:
Aduro BioTech since Feb 2007
Chairman and CEO
Cerus Corporatioin 1991 - 2004
Founder, President and CEO
Chairman and CEO
Cerus Corporatioin 1991 - 2004
Founder, President and CEO
Skills:
Biotechnology
Drug Development
Technology Transfer
Clinical Development
Commercialization
Cancer
Biopharmaceuticals
Immunology
Drug Discovery
Clinical Trials
Global Business Development
Cro
Lifesciences
Vaccines
Fda
Infectious Diseases
Drug Development
Technology Transfer
Clinical Development
Commercialization
Cancer
Biopharmaceuticals
Immunology
Drug Discovery
Clinical Trials
Global Business Development
Cro
Lifesciences
Vaccines
Fda
Infectious Diseases
Chief Executive Officer
view sourceLocation:
San Francisco, CA
Industry:
Biotechnology
Work:
Aduro Biotech
Chief Executive Officer
Chief Executive Officer
Founder And Managing Partner
view sourceLocation:
1717 Michael Way, Calistoga, CA 94515
Industry:
Public Policy
Work:
Isaacs/Jellinek
Founder and Managing Partner
Health Policy Associates
President
Columbia University In the City of New York Jan 1980 - Dec 1996
Professor of Public Health
Founder and Managing Partner
Health Policy Associates
President
Columbia University In the City of New York Jan 1980 - Dec 1996
Professor of Public Health
Education:
Columbia Law School
Doctor of Jurisprudence, Doctorates, Law Brown University
Bachelors, Bachelor of Arts
Doctor of Jurisprudence, Doctorates, Law Brown University
Bachelors, Bachelor of Arts
Skills:
Nonprofits
Program Development
Grant Writing
Program Evaluation
Community Outreach
Public Speaking
Strategic Planning
Public Policy
Program Management
Research
Policy Analysis
Philanthropy
Fundraising
Public Health
Non Profits
Editing
Community Development
Writing
Nonprofit Organizations
Program Development
Grant Writing
Program Evaluation
Community Outreach
Public Speaking
Strategic Planning
Public Policy
Program Management
Research
Policy Analysis
Philanthropy
Fundraising
Public Health
Non Profits
Editing
Community Development
Writing
Nonprofit Organizations
Languages:
English
Stephen J Isaacs
view source
Founder And Managing Partner
view sourceLocation:
San Francisco, CA
Work:
Founder and Managing Partner
Stephen Isaacs
view source
Stephen Isaacs
view source
Ceo At Aduro Biotech
view sourcePosition:
CEO at Aduro BioTech
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Aduro BioTech
CEO
CEO
Googleplus
Stephen Isaacs
Education:
Texas A&M University
Stephen Isaacs
Stephen Isaacs
Stephen Isaacs
Stephen Isaacs
Flickr
Classmates
Stephen Isaacs
view sourceSchools:
ygancio valley high school Concord CA 1963-1967
Community:
Ginger Thompson, Geri Houghton
Stephen D. Isaacs
view sourceSchools:
Middletown School Middletown KY 1951-1955
Community:
Connie Rose, Jerry Rose, Don Augenstein, Faye Routon, John Herrick
Stephen D. Isaacs
view sourceSchools:
Eastern High School Middletown KY 1951-1955
Community:
Gina Padgett, Cecil Trabue
Stephen Isaacs
view sourceSchools:
Jeffersontown High School Jeffersontown KY 1969-1973
Community:
Tracy Bruder
Stephen Isaacs
view sourceSchools:
Clyde Campbell Elementary School Hickory NC 1987-1992, Catawba High School Hickory NC 1999-2003
Community:
Lauren Sherrill, Tywanna Stanford, Bobby White, Larry Weeks, Amanda West, Natonia Cantor, Ry Wade, Ashley Lail, Apo Goul, Ernestine Stanford
Clyde Campbell Elementary...
view sourceGraduates:
Seth Earnhardt (1979-1981),
Stephen Isaacs (1987-1992),
Christy Hedrick (1975-1982),
Amanda Davis (1985-1991)
Stephen Isaacs (1987-1992),
Christy Hedrick (1975-1982),
Amanda Davis (1985-1991)
Catawba High School, Hick...
view sourceGraduates:
Stephen Isaacs (1999-2003),
Rhonda Robbins (1982-1984),
Lauren Sherrill (1996-2000),
Rhonda Smith (1982-1988)
Rhonda Robbins (1982-1984),
Lauren Sherrill (1996-2000),
Rhonda Smith (1982-1988)
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view source
Stephen Isaacs
view sourceYoutube
News
Coronavirus live updates: New Orleans Saints coach tests positive, Spain's death toll tops 1,000
view source- , and Asia looked to be heading for some welcome reprieve on Friday, Stephen Isaacs, chairman of the investment committee at Alvine Capital Management, told CNBC that having entered the crisis with "record levels of leverage" and record levels of overbought stocks, the situation was "unprecedented."
- Date: Mar 20, 2020
- Category: Sports
- Source: Google
Four scenarios that could cause a sudden sell-off in US Treasurys
view source- market-watchers might still be buying, others are incredulous at how bond yields can dip even lower. Stephen Isaacs, the chairman of the investment committee at Alvine Capital and former director of fixed income trading and syndication at Credit Suisse, believes that fixed income has absolutely no value.
- Date: Aug 11, 2016
- Category: Business
- Source: Google
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound
view source- that is, in patients who havent responded to at least two other kinds of treatment for what is one of the deadliest forms of cancer. Aduro CEO Stephen Isaacs said on a conference call today that the failed trial should not be seen as a referendum on the rest of the companys cancer programs. A ne
- Date: May 16, 2016
- Category: Health
- Source: Google
Aduro combo fails in a key pancreatic cancer study
view source- While we are well aware of the very difficult-to-treat nature of late-stage metastatic pancreatic cancer, we are surprised by the divergence of these data from the results of our Phase 2a study, said CEO Stephen Isaacs. But the company hasn't given up hope on its lead program.
- Date: May 16, 2016
- Category: Health
- Source: Google
Myspace
Get Report for Stephen L Isaacs from San Francisco, CA, age ~86